453 related articles for article (PubMed ID: 19302564)
1. Cyclosporine therapy in dermatology.
Mrowietz U; Klein CE; Reich K; Rosenbach T; Ruzicka T; Sebastian M; Werfel T
J Dtsch Dermatol Ges; 2009 May; 7(5):474-9. PubMed ID: 19302564
[No Abstract] [Full Text] [Related]
2. Therapeutic concepts in clinical dermatology: cyclosporine A in immunomediated and other dermatoses.
Capella GL; Casa-Alberighi OD; Finzi AF
Int J Dermatol; 2001 Sep; 40(9):551-61. PubMed ID: 11737448
[No Abstract] [Full Text] [Related]
3. What you should do when people don't get well.
Feldman SR
J Dermatolog Treat; 2007; 18(4):196. PubMed ID: 17671879
[No Abstract] [Full Text] [Related]
4. British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018.
Berth-Jones J; Exton LS; Ladoyanni E; Mohd Mustapa MF; Tebbs VM; Yesudian PD; Levell NJ
Br J Dermatol; 2019 Jun; 180(6):1312-1338. PubMed ID: 30653672
[No Abstract] [Full Text] [Related]
5. Intralesional drug therapy in dermatology.
Deshmukh NS; Belgaumkar VA; Mhaske CB; Doshi BR
Indian J Dermatol Venereol Leprol; 2017; 83(1):127-132. PubMed ID: 27647355
[No Abstract] [Full Text] [Related]
6. [Targeted therapy].
Becker JC; Hertl M
Hautarzt; 2008 Oct; 59(10):783-4. PubMed ID: 18779942
[No Abstract] [Full Text] [Related]
7. Nanodermatology: a bright glimpse just beyond the horizon - part I.
Nasir A
Skin Therapy Lett; 2010 Sep; 15(8):1-4. PubMed ID: 20844848
[TBL] [Abstract][Full Text] [Related]
8. A case of subcorneal pustular dermatosis treated successfully with a combination of cyclosporin and prednisolone.
Karadoğan SK; Aydoğan K; Başkan EB; Tunali S
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):536-7. PubMed ID: 17373984
[No Abstract] [Full Text] [Related]
9. The use of cyclosporine in dermatology: part II.
Ryan C; Amor KT; Menter A
J Am Acad Dermatol; 2010 Dec; 63(6):949-72; quiz 973-4. PubMed ID: 21093660
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in Dermatology.
Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
[TBL] [Abstract][Full Text] [Related]
11. [Systemic therapy].
Baron JM; Homey B
Hautarzt; 2014 Feb; 65(2):88. PubMed ID: 24549479
[No Abstract] [Full Text] [Related]
12. The use of cyclosporine in dermatology: part I.
Amor KT; Ryan C; Menter A
J Am Acad Dermatol; 2010 Dec; 63(6):925-46; quiz 947-8. PubMed ID: 21093659
[TBL] [Abstract][Full Text] [Related]
13. Updates & perspectives on management of common dermatologic disorders.
Del Rosso JQ
J Drugs Dermatol; 2007 Jun; 6(6):662-4. PubMed ID: 17668533
[No Abstract] [Full Text] [Related]
14. More economical use of cyclosporine through combination drug therapy.
Daigle JC
J Am Anim Hosp Assoc; 2002; 38(3):205-8. PubMed ID: 12022403
[No Abstract] [Full Text] [Related]
15. [Thalidomide and thrombosis].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2003 Apr; 130(4):489. PubMed ID: 12843869
[No Abstract] [Full Text] [Related]
16. Can we still suggest the topical cyclosporin treatment in cutaneous disorders?
Vena GA; Cassano N
J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):18-9. PubMed ID: 11451314
[No Abstract] [Full Text] [Related]
17. [Biochemistry, pharmacology and toxicology of urea].
Raab W
Hautarzt; 1989; 40 Suppl 9():23-6. PubMed ID: 2681074
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy.
van de Kerkhof PC; Braathen LR
Eur J Dermatol; 2009; 19(3):297-301. PubMed ID: 19473957
[No Abstract] [Full Text] [Related]
19. Topical treatments in dermatology still going strong.
van de Kerkhof PC
J Dermatolog Treat; 2010 May; 21(3):125. PubMed ID: 20394487
[No Abstract] [Full Text] [Related]
20. Thalidomide for dermatology: a review of clinical uses and adverse effects.
Faver IR; Guerra SG; Su WP; el-Azhary R
Int J Dermatol; 2005 Jan; 44(1):61-7. PubMed ID: 15663665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
